nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Methotrexate—muscle cancer	0.2	0.236	CbGbCtD
Olmesartan—ABCC2—Vincristine—muscle cancer	0.169	0.199	CbGbCtD
Olmesartan—ABCC2—Etoposide—muscle cancer	0.155	0.183	CbGbCtD
Olmesartan—SLCO1B1—Methotrexate—muscle cancer	0.117	0.137	CbGbCtD
Olmesartan—ABCC2—Doxorubicin—muscle cancer	0.106	0.125	CbGbCtD
Olmesartan—ABCC2—Methotrexate—muscle cancer	0.102	0.121	CbGbCtD
Olmesartan—Aplastic anaemia—Doxorubicin—muscle cancer	0.000558	0.0037	CcSEcCtD
Olmesartan—Vertigo—Vincristine—muscle cancer	0.000556	0.00368	CcSEcCtD
Olmesartan—Leukopenia—Vincristine—muscle cancer	0.000554	0.00367	CcSEcCtD
Olmesartan—Thrombocytopenia—Dactinomycin—muscle cancer	0.000553	0.00367	CcSEcCtD
Olmesartan—Renal failure acute—Methotrexate—muscle cancer	0.00054	0.00358	CcSEcCtD
Olmesartan—Anorexia—Dactinomycin—muscle cancer	0.000539	0.00357	CcSEcCtD
Olmesartan—Myalgia—Vincristine—muscle cancer	0.000527	0.00349	CcSEcCtD
Olmesartan—Angiopathy—Etoposide—muscle cancer	0.000522	0.00346	CcSEcCtD
Olmesartan—Mediastinal disorder—Etoposide—muscle cancer	0.000519	0.00344	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000515	0.00341	CcSEcCtD
Olmesartan—Alopecia—Etoposide—muscle cancer	0.000509	0.00337	CcSEcCtD
Olmesartan—Lethargy—Methotrexate—muscle cancer	0.000509	0.00337	CcSEcCtD
Olmesartan—Anaphylactic shock—Vincristine—muscle cancer	0.000505	0.00335	CcSEcCtD
Olmesartan—Oedema—Vincristine—muscle cancer	0.000505	0.00335	CcSEcCtD
Olmesartan—Infection—Vincristine—muscle cancer	0.000502	0.00332	CcSEcCtD
Olmesartan—Diabetes mellitus—Doxorubicin—muscle cancer	0.000496	0.00329	CcSEcCtD
Olmesartan—Nervous system disorder—Vincristine—muscle cancer	0.000495	0.00328	CcSEcCtD
Olmesartan—Thrombocytopenia—Vincristine—muscle cancer	0.000494	0.00328	CcSEcCtD
Olmesartan—Decreased appetite—Dactinomycin—muscle cancer	0.000491	0.00326	CcSEcCtD
Olmesartan—Hyperhidrosis—Vincristine—muscle cancer	0.000488	0.00324	CcSEcCtD
Olmesartan—Fatigue—Dactinomycin—muscle cancer	0.000487	0.00323	CcSEcCtD
Olmesartan—Back pain—Etoposide—muscle cancer	0.000485	0.00321	CcSEcCtD
Olmesartan—Pain—Dactinomycin—muscle cancer	0.000483	0.0032	CcSEcCtD
Olmesartan—Muscle spasms—Etoposide—muscle cancer	0.000482	0.00319	CcSEcCtD
Olmesartan—Anorexia—Vincristine—muscle cancer	0.000481	0.00319	CcSEcCtD
Olmesartan—Eczema—Doxorubicin—muscle cancer	0.00048	0.00318	CcSEcCtD
Olmesartan—Hypotension—Vincristine—muscle cancer	0.000472	0.00313	CcSEcCtD
Olmesartan—Renal failure acute—Doxorubicin—muscle cancer	0.000467	0.0031	CcSEcCtD
Olmesartan—Feeling abnormal—Dactinomycin—muscle cancer	0.000466	0.00309	CcSEcCtD
Olmesartan—Ill-defined disorder—Etoposide—muscle cancer	0.000465	0.00308	CcSEcCtD
Olmesartan—Anaemia—Etoposide—muscle cancer	0.000463	0.00307	CcSEcCtD
Olmesartan—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000462	0.00306	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00046	0.00305	CcSEcCtD
Olmesartan—Insomnia—Vincristine—muscle cancer	0.000457	0.00303	CcSEcCtD
Olmesartan—Malaise—Etoposide—muscle cancer	0.000452	0.003	CcSEcCtD
Olmesartan—Vertigo—Etoposide—muscle cancer	0.00045	0.00298	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000449	0.00297	CcSEcCtD
Olmesartan—Leukopenia—Etoposide—muscle cancer	0.000449	0.00297	CcSEcCtD
Olmesartan—Body temperature increased—Dactinomycin—muscle cancer	0.000447	0.00296	CcSEcCtD
Olmesartan—Abdominal pain—Dactinomycin—muscle cancer	0.000447	0.00296	CcSEcCtD
Olmesartan—Loss of consciousness—Etoposide—muscle cancer	0.00044	0.00292	CcSEcCtD
Olmesartan—Lethargy—Doxorubicin—muscle cancer	0.00044	0.00292	CcSEcCtD
Olmesartan—Decreased appetite—Vincristine—muscle cancer	0.000439	0.00291	CcSEcCtD
Olmesartan—Cough—Etoposide—muscle cancer	0.000437	0.0029	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Vincristine—muscle cancer	0.000436	0.00289	CcSEcCtD
Olmesartan—Fatigue—Vincristine—muscle cancer	0.000435	0.00289	CcSEcCtD
Olmesartan—Hyponatraemia—Doxorubicin—muscle cancer	0.000433	0.00287	CcSEcCtD
Olmesartan—Pain—Vincristine—muscle cancer	0.000432	0.00286	CcSEcCtD
Olmesartan—Constipation—Vincristine—muscle cancer	0.000432	0.00286	CcSEcCtD
Olmesartan—Pain in extremity—Doxorubicin—muscle cancer	0.000432	0.00286	CcSEcCtD
Olmesartan—Chest pain—Etoposide—muscle cancer	0.000427	0.00283	CcSEcCtD
Olmesartan—Eosinophilia—Methotrexate—muscle cancer	0.000427	0.00283	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000424	0.00281	CcSEcCtD
Olmesartan—Pancreatitis—Methotrexate—muscle cancer	0.000422	0.0028	CcSEcCtD
Olmesartan—Discomfort—Etoposide—muscle cancer	0.000422	0.00279	CcSEcCtD
Olmesartan—Face oedema—Doxorubicin—muscle cancer	0.000417	0.00276	CcSEcCtD
Olmesartan—Gastrointestinal pain—Vincristine—muscle cancer	0.000413	0.00274	CcSEcCtD
Olmesartan—Pancytopenia—Methotrexate—muscle cancer	0.000409	0.00271	CcSEcCtD
Olmesartan—Anaphylactic shock—Etoposide—muscle cancer	0.000409	0.00271	CcSEcCtD
Olmesartan—Infection—Etoposide—muscle cancer	0.000406	0.00269	CcSEcCtD
Olmesartan—Asthenia—Dactinomycin—muscle cancer	0.000405	0.00269	CcSEcCtD
Olmesartan—Blood creatinine increased—Doxorubicin—muscle cancer	0.000404	0.00268	CcSEcCtD
Olmesartan—Neutropenia—Methotrexate—muscle cancer	0.000403	0.00267	CcSEcCtD
Olmesartan—Thrombocytopenia—Etoposide—muscle cancer	0.0004	0.00265	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Methotrexate—muscle cancer	0.0004	0.00265	CcSEcCtD
Olmesartan—Tachycardia—Etoposide—muscle cancer	0.000399	0.00265	CcSEcCtD
Olmesartan—Abdominal pain—Vincristine—muscle cancer	0.000399	0.00265	CcSEcCtD
Olmesartan—Body temperature increased—Vincristine—muscle cancer	0.000399	0.00265	CcSEcCtD
Olmesartan—Skin disorder—Etoposide—muscle cancer	0.000397	0.00263	CcSEcCtD
Olmesartan—Erectile dysfunction—Methotrexate—muscle cancer	0.000397	0.00263	CcSEcCtD
Olmesartan—Hyperhidrosis—Etoposide—muscle cancer	0.000395	0.00262	CcSEcCtD
Olmesartan—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000394	0.00261	CcSEcCtD
Olmesartan—Photosensitivity reaction—Methotrexate—muscle cancer	0.000393	0.00261	CcSEcCtD
Olmesartan—Hypokalaemia—Doxorubicin—muscle cancer	0.000393	0.0026	CcSEcCtD
Olmesartan—Anorexia—Etoposide—muscle cancer	0.00039	0.00258	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000389	0.00258	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000389	0.00258	CcSEcCtD
Olmesartan—Diarrhoea—Dactinomycin—muscle cancer	0.000387	0.00256	CcSEcCtD
Olmesartan—Pneumonia—Methotrexate—muscle cancer	0.000386	0.00256	CcSEcCtD
Olmesartan—Nasopharyngitis—Doxorubicin—muscle cancer	0.000386	0.00256	CcSEcCtD
Olmesartan—Infestation NOS—Methotrexate—muscle cancer	0.000384	0.00255	CcSEcCtD
Olmesartan—Infestation—Methotrexate—muscle cancer	0.000384	0.00255	CcSEcCtD
Olmesartan—Hypotension—Etoposide—muscle cancer	0.000382	0.00253	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000381	0.00252	CcSEcCtD
Olmesartan—Renal failure—Methotrexate—muscle cancer	0.000378	0.0025	CcSEcCtD
Olmesartan—Influenza—Doxorubicin—muscle cancer	0.000373	0.00247	CcSEcCtD
Olmesartan—Eosinophilia—Doxorubicin—muscle cancer	0.000369	0.00245	CcSEcCtD
Olmesartan—Haematuria—Methotrexate—muscle cancer	0.000366	0.00243	CcSEcCtD
Olmesartan—Pancreatitis—Doxorubicin—muscle cancer	0.000366	0.00242	CcSEcCtD
Olmesartan—Angina pectoris—Doxorubicin—muscle cancer	0.000363	0.00241	CcSEcCtD
Olmesartan—Asthenia—Vincristine—muscle cancer	0.000362	0.0024	CcSEcCtD
Olmesartan—Vomiting—Dactinomycin—muscle cancer	0.000359	0.00238	CcSEcCtD
Olmesartan—Bronchitis—Doxorubicin—muscle cancer	0.000359	0.00238	CcSEcCtD
Olmesartan—Agranulocytosis—Methotrexate—muscle cancer	0.000358	0.00238	CcSEcCtD
Olmesartan—Rash—Dactinomycin—muscle cancer	0.000356	0.00236	CcSEcCtD
Olmesartan—Decreased appetite—Etoposide—muscle cancer	0.000356	0.00236	CcSEcCtD
Olmesartan—Pancytopenia—Doxorubicin—muscle cancer	0.000354	0.00235	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Etoposide—muscle cancer	0.000353	0.00234	CcSEcCtD
Olmesartan—Fatigue—Etoposide—muscle cancer	0.000353	0.00234	CcSEcCtD
Olmesartan—Pain—Etoposide—muscle cancer	0.00035	0.00232	CcSEcCtD
Olmesartan—Constipation—Etoposide—muscle cancer	0.00035	0.00232	CcSEcCtD
Olmesartan—Neutropenia—Doxorubicin—muscle cancer	0.000349	0.00231	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000347	0.0023	CcSEcCtD
Olmesartan—Diarrhoea—Vincristine—muscle cancer	0.000345	0.00229	CcSEcCtD
Olmesartan—Pharyngitis—Methotrexate—muscle cancer	0.000342	0.00227	CcSEcCtD
Olmesartan—Urinary tract disorder—Methotrexate—muscle cancer	0.000341	0.00226	CcSEcCtD
Olmesartan—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000341	0.00226	CcSEcCtD
Olmesartan—Urethral disorder—Methotrexate—muscle cancer	0.000338	0.00224	CcSEcCtD
Olmesartan—Feeling abnormal—Etoposide—muscle cancer	0.000337	0.00223	CcSEcCtD
Olmesartan—Hyperglycaemia—Doxorubicin—muscle cancer	0.000337	0.00223	CcSEcCtD
Olmesartan—Nausea—Dactinomycin—muscle cancer	0.000336	0.00222	CcSEcCtD
Olmesartan—Pneumonia—Doxorubicin—muscle cancer	0.000335	0.00222	CcSEcCtD
Olmesartan—Gastrointestinal pain—Etoposide—muscle cancer	0.000334	0.00222	CcSEcCtD
Olmesartan—Dizziness—Vincristine—muscle cancer	0.000334	0.00221	CcSEcCtD
Olmesartan—Infestation NOS—Doxorubicin—muscle cancer	0.000333	0.0022	CcSEcCtD
Olmesartan—Infestation—Doxorubicin—muscle cancer	0.000333	0.0022	CcSEcCtD
Olmesartan—Renal failure—Doxorubicin—muscle cancer	0.000327	0.00217	CcSEcCtD
Olmesartan—Urticaria—Etoposide—muscle cancer	0.000325	0.00215	CcSEcCtD
Olmesartan—Jaundice—Doxorubicin—muscle cancer	0.000324	0.00215	CcSEcCtD
Olmesartan—Abdominal pain—Etoposide—muscle cancer	0.000323	0.00214	CcSEcCtD
Olmesartan—Body temperature increased—Etoposide—muscle cancer	0.000323	0.00214	CcSEcCtD
Olmesartan—Urinary tract infection—Doxorubicin—muscle cancer	0.000323	0.00214	CcSEcCtD
Olmesartan—Vomiting—Vincristine—muscle cancer	0.000321	0.00213	CcSEcCtD
Olmesartan—Rash—Vincristine—muscle cancer	0.000318	0.00211	CcSEcCtD
Olmesartan—Dermatitis—Vincristine—muscle cancer	0.000318	0.00211	CcSEcCtD
Olmesartan—Haematuria—Doxorubicin—muscle cancer	0.000317	0.0021	CcSEcCtD
Olmesartan—Headache—Vincristine—muscle cancer	0.000316	0.0021	CcSEcCtD
Olmesartan—Angiopathy—Methotrexate—muscle cancer	0.000313	0.00207	CcSEcCtD
Olmesartan—Sinusitis—Doxorubicin—muscle cancer	0.000312	0.00207	CcSEcCtD
Olmesartan—Mediastinal disorder—Methotrexate—muscle cancer	0.000311	0.00206	CcSEcCtD
Olmesartan—Agranulocytosis—Doxorubicin—muscle cancer	0.00031	0.00206	CcSEcCtD
Olmesartan—Alopecia—Methotrexate—muscle cancer	0.000305	0.00202	CcSEcCtD
Olmesartan—Mental disorder—Methotrexate—muscle cancer	0.000302	0.002	CcSEcCtD
Olmesartan—Malnutrition—Methotrexate—muscle cancer	0.0003	0.00199	CcSEcCtD
Olmesartan—Nausea—Vincristine—muscle cancer	0.0003	0.00199	CcSEcCtD
Olmesartan—Rhinitis—Doxorubicin—muscle cancer	0.000299	0.00198	CcSEcCtD
Olmesartan—Pharyngitis—Doxorubicin—muscle cancer	0.000296	0.00196	CcSEcCtD
Olmesartan—Urinary tract disorder—Doxorubicin—muscle cancer	0.000295	0.00195	CcSEcCtD
Olmesartan—Oedema peripheral—Doxorubicin—muscle cancer	0.000294	0.00195	CcSEcCtD
Olmesartan—Asthenia—Etoposide—muscle cancer	0.000293	0.00194	CcSEcCtD
Olmesartan—Connective tissue disorder—Doxorubicin—muscle cancer	0.000293	0.00194	CcSEcCtD
Olmesartan—Urethral disorder—Doxorubicin—muscle cancer	0.000293	0.00194	CcSEcCtD
Olmesartan—Back pain—Methotrexate—muscle cancer	0.00029	0.00192	CcSEcCtD
Olmesartan—Pruritus—Etoposide—muscle cancer	0.000289	0.00192	CcSEcCtD
Olmesartan—Vision blurred—Methotrexate—muscle cancer	0.000283	0.00188	CcSEcCtD
Olmesartan—Diarrhoea—Etoposide—muscle cancer	0.00028	0.00185	CcSEcCtD
Olmesartan—Ill-defined disorder—Methotrexate—muscle cancer	0.000279	0.00185	CcSEcCtD
Olmesartan—Anaemia—Methotrexate—muscle cancer	0.000277	0.00184	CcSEcCtD
Olmesartan—Angiopathy—Doxorubicin—muscle cancer	0.000271	0.0018	CcSEcCtD
Olmesartan—Malaise—Methotrexate—muscle cancer	0.000271	0.00179	CcSEcCtD
Olmesartan—Dizziness—Etoposide—muscle cancer	0.00027	0.00179	CcSEcCtD
Olmesartan—Vertigo—Methotrexate—muscle cancer	0.00027	0.00179	CcSEcCtD
Olmesartan—Mediastinal disorder—Doxorubicin—muscle cancer	0.000269	0.00178	CcSEcCtD
Olmesartan—Leukopenia—Methotrexate—muscle cancer	0.000269	0.00178	CcSEcCtD
Olmesartan—Arrhythmia—Doxorubicin—muscle cancer	0.000267	0.00177	CcSEcCtD
Olmesartan—Alopecia—Doxorubicin—muscle cancer	0.000264	0.00175	CcSEcCtD
Olmesartan—Cough—Methotrexate—muscle cancer	0.000262	0.00174	CcSEcCtD
Olmesartan—Mental disorder—Doxorubicin—muscle cancer	0.000262	0.00173	CcSEcCtD
Olmesartan—Vomiting—Etoposide—muscle cancer	0.00026	0.00172	CcSEcCtD
Olmesartan—Malnutrition—Doxorubicin—muscle cancer	0.00026	0.00172	CcSEcCtD
Olmesartan—Rash—Etoposide—muscle cancer	0.000258	0.00171	CcSEcCtD
Olmesartan—Dermatitis—Etoposide—muscle cancer	0.000258	0.00171	CcSEcCtD
Olmesartan—Headache—Etoposide—muscle cancer	0.000256	0.0017	CcSEcCtD
Olmesartan—Chest pain—Methotrexate—muscle cancer	0.000256	0.00169	CcSEcCtD
Olmesartan—Arthralgia—Methotrexate—muscle cancer	0.000256	0.00169	CcSEcCtD
Olmesartan—Myalgia—Methotrexate—muscle cancer	0.000256	0.00169	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000254	0.00168	CcSEcCtD
Olmesartan—Discomfort—Methotrexate—muscle cancer	0.000252	0.00167	CcSEcCtD
Olmesartan—Back pain—Doxorubicin—muscle cancer	0.000251	0.00167	CcSEcCtD
Olmesartan—Muscle spasms—Doxorubicin—muscle cancer	0.00025	0.00166	CcSEcCtD
Olmesartan—Anaphylactic shock—Methotrexate—muscle cancer	0.000245	0.00162	CcSEcCtD
Olmesartan—Vision blurred—Doxorubicin—muscle cancer	0.000245	0.00162	CcSEcCtD
Olmesartan—Infection—Methotrexate—muscle cancer	0.000243	0.00161	CcSEcCtD
Olmesartan—Nausea—Etoposide—muscle cancer	0.000243	0.00161	CcSEcCtD
Olmesartan—Ill-defined disorder—Doxorubicin—muscle cancer	0.000241	0.0016	CcSEcCtD
Olmesartan—Nervous system disorder—Methotrexate—muscle cancer	0.00024	0.00159	CcSEcCtD
Olmesartan—Anaemia—Doxorubicin—muscle cancer	0.00024	0.00159	CcSEcCtD
Olmesartan—Thrombocytopenia—Methotrexate—muscle cancer	0.00024	0.00159	CcSEcCtD
Olmesartan—Agitation—Doxorubicin—muscle cancer	0.000239	0.00158	CcSEcCtD
Olmesartan—Skin disorder—Methotrexate—muscle cancer	0.000238	0.00158	CcSEcCtD
Olmesartan—Hyperhidrosis—Methotrexate—muscle cancer	0.000237	0.00157	CcSEcCtD
Olmesartan—Malaise—Doxorubicin—muscle cancer	0.000234	0.00155	CcSEcCtD
Olmesartan—Vertigo—Doxorubicin—muscle cancer	0.000234	0.00155	CcSEcCtD
Olmesartan—Anorexia—Methotrexate—muscle cancer	0.000234	0.00155	CcSEcCtD
Olmesartan—Syncope—Doxorubicin—muscle cancer	0.000233	0.00154	CcSEcCtD
Olmesartan—Leukopenia—Doxorubicin—muscle cancer	0.000233	0.00154	CcSEcCtD
Olmesartan—Palpitations—Doxorubicin—muscle cancer	0.00023	0.00152	CcSEcCtD
Olmesartan—Hypotension—Methotrexate—muscle cancer	0.000229	0.00152	CcSEcCtD
Olmesartan—Loss of consciousness—Doxorubicin—muscle cancer	0.000228	0.00151	CcSEcCtD
Olmesartan—Cough—Doxorubicin—muscle cancer	0.000227	0.0015	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000223	0.00148	CcSEcCtD
Olmesartan—Insomnia—Methotrexate—muscle cancer	0.000222	0.00147	CcSEcCtD
Olmesartan—Arthralgia—Doxorubicin—muscle cancer	0.000221	0.00147	CcSEcCtD
Olmesartan—Chest pain—Doxorubicin—muscle cancer	0.000221	0.00147	CcSEcCtD
Olmesartan—Myalgia—Doxorubicin—muscle cancer	0.000221	0.00147	CcSEcCtD
Olmesartan—Anxiety—Doxorubicin—muscle cancer	0.000221	0.00146	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00022	0.00146	CcSEcCtD
Olmesartan—Discomfort—Doxorubicin—muscle cancer	0.000219	0.00145	CcSEcCtD
Olmesartan—Dyspepsia—Methotrexate—muscle cancer	0.000216	0.00143	CcSEcCtD
Olmesartan—Decreased appetite—Methotrexate—muscle cancer	0.000213	0.00141	CcSEcCtD
Olmesartan—Oedema—Doxorubicin—muscle cancer	0.000212	0.00141	CcSEcCtD
Olmesartan—Anaphylactic shock—Doxorubicin—muscle cancer	0.000212	0.00141	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000212	0.0014	CcSEcCtD
Olmesartan—Fatigue—Methotrexate—muscle cancer	0.000211	0.0014	CcSEcCtD
Olmesartan—Infection—Doxorubicin—muscle cancer	0.000211	0.0014	CcSEcCtD
Olmesartan—Pain—Methotrexate—muscle cancer	0.000209	0.00139	CcSEcCtD
Olmesartan—Shock—Doxorubicin—muscle cancer	0.000209	0.00138	CcSEcCtD
Olmesartan—Nervous system disorder—Doxorubicin—muscle cancer	0.000208	0.00138	CcSEcCtD
Olmesartan—Thrombocytopenia—Doxorubicin—muscle cancer	0.000208	0.00138	CcSEcCtD
Olmesartan—Tachycardia—Doxorubicin—muscle cancer	0.000207	0.00137	CcSEcCtD
Olmesartan—Skin disorder—Doxorubicin—muscle cancer	0.000206	0.00137	CcSEcCtD
Olmesartan—Hyperhidrosis—Doxorubicin—muscle cancer	0.000205	0.00136	CcSEcCtD
Olmesartan—Anorexia—Doxorubicin—muscle cancer	0.000202	0.00134	CcSEcCtD
Olmesartan—Feeling abnormal—Methotrexate—muscle cancer	0.000202	0.00134	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methotrexate—muscle cancer	0.0002	0.00133	CcSEcCtD
Olmesartan—Hypotension—Doxorubicin—muscle cancer	0.000198	0.00131	CcSEcCtD
Olmesartan—Urticaria—Methotrexate—muscle cancer	0.000195	0.00129	CcSEcCtD
Olmesartan—Abdominal pain—Methotrexate—muscle cancer	0.000194	0.00128	CcSEcCtD
Olmesartan—Body temperature increased—Methotrexate—muscle cancer	0.000194	0.00128	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000193	0.00128	CcSEcCtD
Olmesartan—Insomnia—Doxorubicin—muscle cancer	0.000192	0.00127	CcSEcCtD
Olmesartan—Dyspepsia—Doxorubicin—muscle cancer	0.000187	0.00124	CcSEcCtD
Olmesartan—Decreased appetite—Doxorubicin—muscle cancer	0.000184	0.00122	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000183	0.00121	CcSEcCtD
Olmesartan—Fatigue—Doxorubicin—muscle cancer	0.000183	0.00121	CcSEcCtD
Olmesartan—Pain—Doxorubicin—muscle cancer	0.000181	0.0012	CcSEcCtD
Olmesartan—Constipation—Doxorubicin—muscle cancer	0.000181	0.0012	CcSEcCtD
Olmesartan—Asthenia—Methotrexate—muscle cancer	0.000176	0.00117	CcSEcCtD
Olmesartan—Feeling abnormal—Doxorubicin—muscle cancer	0.000175	0.00116	CcSEcCtD
Olmesartan—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000173	0.00115	CcSEcCtD
Olmesartan—Pruritus—Methotrexate—muscle cancer	0.000173	0.00115	CcSEcCtD
Olmesartan—Urticaria—Doxorubicin—muscle cancer	0.000169	0.00112	CcSEcCtD
Olmesartan—Body temperature increased—Doxorubicin—muscle cancer	0.000168	0.00111	CcSEcCtD
Olmesartan—Abdominal pain—Doxorubicin—muscle cancer	0.000168	0.00111	CcSEcCtD
Olmesartan—Diarrhoea—Methotrexate—muscle cancer	0.000168	0.00111	CcSEcCtD
Olmesartan—Dizziness—Methotrexate—muscle cancer	0.000162	0.00107	CcSEcCtD
Olmesartan—Vomiting—Methotrexate—muscle cancer	0.000156	0.00103	CcSEcCtD
Olmesartan—Rash—Methotrexate—muscle cancer	0.000154	0.00102	CcSEcCtD
Olmesartan—Dermatitis—Methotrexate—muscle cancer	0.000154	0.00102	CcSEcCtD
Olmesartan—Headache—Methotrexate—muscle cancer	0.000153	0.00102	CcSEcCtD
Olmesartan—Asthenia—Doxorubicin—muscle cancer	0.000152	0.00101	CcSEcCtD
Olmesartan—Pruritus—Doxorubicin—muscle cancer	0.00015	0.000995	CcSEcCtD
Olmesartan—Nausea—Methotrexate—muscle cancer	0.000146	0.000964	CcSEcCtD
Olmesartan—Diarrhoea—Doxorubicin—muscle cancer	0.000145	0.000962	CcSEcCtD
Olmesartan—Dizziness—Doxorubicin—muscle cancer	0.00014	0.00093	CcSEcCtD
Olmesartan—Vomiting—Doxorubicin—muscle cancer	0.000135	0.000894	CcSEcCtD
Olmesartan—Rash—Doxorubicin—muscle cancer	0.000134	0.000887	CcSEcCtD
Olmesartan—Dermatitis—Doxorubicin—muscle cancer	0.000134	0.000886	CcSEcCtD
Olmesartan—Headache—Doxorubicin—muscle cancer	0.000133	0.000881	CcSEcCtD
Olmesartan—Nausea—Doxorubicin—muscle cancer	0.000126	0.000835	CcSEcCtD
